The dog vaccines global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Dog Vaccines Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The dog vaccines market size has grown strongly in recent years. It will grow from $3.43 billion in 2023 to $3.64 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to innovative vaccination protocols, zoonotic disease awareness, globalization and travel, educational campaigns, research and vaccine development, veterinary practice evolution.
The dog vaccines market size is expected to see strong growth in the next few years. It will grow to $4.76 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing pet adoption rates, health consciousness among pet owners, government regulations and mandates, rising humanization of pets, prevalence of canine diseases. Major trends in the forecast period include pet insurance and healthcare plans, availability and accessibility, customized vaccination protocols, changing disease patterns, development of novel vaccines.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report
Scope Of Dog Vaccines Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Dog Vaccines Market Overview
Market Drivers –
The rise in the adoption of pet dogs is expected to propel the dog vaccines market going forward. A pet dog refers to a companion animal that is domesticated or tamed and lives within a home. A dog vaccine is an injection that is given to dogs in series starting at the puppy stage and continuing into adulthood. This vaccine stimulates the immune system which helps dogs to encounter microorganisms and not get sick or have less severe symptoms. For instance, according to the National Pet Owners Survey by the American Pet Products Association 2021-2022, a US-based not-for-profit industry association, 70% of households in the United States owned a pet, which was equal to 90.5 million homes. Out of this, a total of 69 million U.S. households owned a dog as a pet, which was the highest compared to other animals as pets. Thus, the rise in the adoption of pet dogs is driving the growth of the dog vaccines market.
Market Trends –
Technological advancement is a key trend gaining popularity in the dog vaccines market. Major companies operating in the dog vaccines market are advancing toward the use of novel technology for vaccine development. For instance, in September 2022, Merck Animal Health, a US-based company providing veterinary pharmaceuticals, vaccines, and technology solutions, launched Nobivac Intra-Trac Oral BbPi, the first oral vaccine with mucosal protection and easy oral administration. It is used for the vaccination of healthy dogs aged 7 weeks or older against canine parainfluenza virus and Bordetella bronchiseptica. Additionally, it includes the novel technology, Immuno-Mist-R technology by Intervet, a Merck & Co subsidiary. This revolutionary technology, Immuno-Mist-RTM, dramatically increases mucosal surface area contact.
The dog vaccines market covered in this report is segmented –
1) By Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines
2) By Route Of Administration: Subcutaneous, Intramuscular, Intranasal
3) By Application: Below 6 Months, Above 6 Months
Get an inside scoop of the dog vaccines market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8443&type=smp
Regional Insights –
Asia-Pacific was the largest region in the dog vaccines market in 2023. The regions covered in the dog vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the dog vaccines market report are Bayer AG, Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation, Merck & Co. Inc., Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Sanofi S.A., CyMedica Orthopedics Inc., Creative Biolabs Inc., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, High Speed Digieal Processor Architecture Pvt. Ltd., Dechra Pharmaceuticals plc, Idexx Laboratories Inc., Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH, Biovac Ltd., Zenex Animal Health India Pvt. Ltd., Instituto Rosenbusch S A, Pfizer Inc.
1. Executive Summary
2. Dog Vaccines Market Report Structure
3. Dog Vaccines Market Trends And Strategies
4. Dog Vaccines Market – Macro Economic Scenario
5. Dog Vaccines Market Size And Growth
…..
27. Dog Vaccines Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
